Patents by Inventor Andrew T. Koppisch

Andrew T. Koppisch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12208069
    Abstract: Methods and compositions related to molecules and formulations comprising antibiofilm materials are provide, including new formulations of Deep Eutectic Solvents (DES) that are chemically related to choline geranate. Specifically, geranic acid (a component of choline geranate DES) is a molecule from the isoprenoid/terpene family of compounds. Other members of this family as DES components include isoprenoid acids and chemical derivatives thereof.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: January 28, 2025
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY, TRIAD NATIONAL SECURITY LLC, DIXIE STATE UNIVERSITY, THE COLLEGE OF NEW JERSEY
    Inventors: Andrew T. Koppisch, Gerrick E. Lindberg, David T. Fox, Joseph Baker, Alexanndra J. Heyert, Rico Del Sesto, Joshua R. Greene
  • Publication number: 20220096402
    Abstract: Methods and compositions related to molecules and formulations comprising antibiofilm materials are provide, including new formulations of Deep Eutectic Solvents (DES) that are chemically related to choline geranate. Specifically, geranic acid (a component of choline geranate DES) is a molecule from the isoprenoid/terpene family of compounds. Other members of this family as DES components include isoprenoid acids and chemical derivatives thereof.
    Type: Application
    Filed: December 1, 2021
    Publication date: March 31, 2022
    Inventors: Andrew T. Koppisch, Gerrick E. Lindberg, David T. Fox, Joseph Baker, Alexanndra J. Heyert, Rico Del Sesto, Joshua R. Greene
  • Patent number: 11213497
    Abstract: Methods and compositions related to molecules and formulations comprising antibiofilm materials are provide, including new formulations of Deep Eutectic Solvents (DES) that are chemically related to choline geranate. Specifically, geranic acid (a component of choline geranate DES) is a molecule from the isoprenoid/terpene family of compounds. Other members of this family as DES components include isoprenoid acids and chemical derivatives thereof.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: January 4, 2022
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY, TRIAD NATIONAL SECURITY, LLC, DIXIE STATE UNIVERSITY, THE COLLEGE OF NEW JERSEY
    Inventors: Andrew T. Koppisch, Gerrick E. Lindberg, David T. Fox, Joseph Baker, Alexanndra J. Heyert, Rico Del Sesto, Joshua R. Greene
  • Publication number: 20210404966
    Abstract: The present disclosure describes a novel system and method for providing a fast, inexpensive and reliable diagnostic test for indicating the presence of a biological threat. This test utilizes surface-enhanced Raman spectroscopy to interrogate a sample comprising metallic plasmonic particles suspected of contamination with the biological threat. The Raman spectrum is analyzed for specific Raman shifts that are characteristic of an interaction of the biological threat with the metallic plasmonic particles to produce a diagnostic result.
    Type: Application
    Filed: April 6, 2021
    Publication date: December 30, 2021
    Inventors: Miguel Jose Yacaman, Paul S. Keim, Andrew T. Koppisch, Robert Keller, David M. Wagner, Jason Sahl
  • Publication number: 20210169075
    Abstract: Compositions and methods of inhibiting bacterial growth and biofilm formation on surfaces by contacting the surface with an aqueous solution of at least one compound among a terpene, terpene alcohol, and acid obtained from a plant containing such a compound. Exemplary surfaces include tubing used in beer delivery lines in a brewery/restaurant setting, and medical tubing.
    Type: Application
    Filed: December 1, 2020
    Publication date: June 10, 2021
    Inventors: Andrew T. Koppisch, Cameron Selna, Emily K. Cope, Nathan Christopher Nieto, Campbell Morrissy
  • Patent number: 10877035
    Abstract: X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical. For estimating the binding selectivities of a chemical versus chemical analogs, for measuring post translational modification of proteins, and for drug manufacturing.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: December 29, 2020
    Assignee: ICAGEN, LLC
    Inventors: Eva R. Birnbaum, Andrew T. Koppisch, Sharon M. Baldwin, Benjamin P. Warner, T. Mark McCleskey, Jennifer A. Berger, Jeffrey J. Stewart, Michael N. Harris, Anthony K. Burrell
  • Publication number: 20200323799
    Abstract: Methods and compositions related to molecules and formulations comprising antibiofilm materials are provide, including new formulations of Deep Eutectic Solvents (DES) that are chemically related to choline geranate. Specifically, geranic acid (a component of choline geranate DES) is a molecule from the isoprenoid/terpene family of compounds. Other members of this family as DES components include isoprenoid acids and chemical derivatives thereof.
    Type: Application
    Filed: May 31, 2018
    Publication date: October 15, 2020
    Inventors: Andrew T. Koppisch, Gerrick E. Lindberg, David T. Fox, Joseph Baker, Alexanndra J. Heyert, Rico Del Sesto, Joshua R. Greene
  • Publication number: 20150309021
    Abstract: X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical. For estimating the binding selectivities of a chemical versus chemical analogs, for measuring post translational modification of proteins, and for drug manufacturing.
    Type: Application
    Filed: April 22, 2015
    Publication date: October 29, 2015
    Inventors: Eva R. Birnbaum, Andrew T. Koppisch, Sharon M. Baldwin, Benjamin P. Warner, T. Mark McCleskey, Jennifer A. Berger, Jeffrey J. Stewart, Michael N. Harris, Anthony K. Burrell
  • Patent number: 8920673
    Abstract: Phosphonium-based room temperature ionic liquids (“RTILs”) were prepared. They were used as matrices for Matrix-Assisted Laser Desorption Ionization (MALDI) mass spectrometry and also for preparing samples of dyes for analysis.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: December 30, 2014
    Assignee: Los Alamos National Security, LLC
    Inventors: Rico E. Del Sesto, Andrew T. Koppisch, Katherine S. Lovejoy, Geraldine M. Purdy
  • Publication number: 20120196339
    Abstract: Disclosed herein are methods for producing compounds (such as 3,4-dihydroxybenzoate, catechol, cis,cis-muconate, or ?-carboxy-cis,cis-muconic acid) utilizing biosynthetic pathways in prokaryotic organisms expressing one or more heterologous genes. In some embodiments, the method includes expressing a heterologous asbF gene (for example, a gene having dehydroshikimate dehydratase activity) in a prokaryotic cell under conditions sufficient to produce the one or more compounds and purifying the compound. In additional embodiments, the method further includes expressing one or more of a heterologous 3,4-DHB decarboxylase gene, a heterologous catechol 1,2-dioxygenase gene, and a heterologous 3,4-DHB dioxygenase gene in the prokaryotic cell and purifying the compound.
    Type: Application
    Filed: January 31, 2011
    Publication date: August 2, 2012
    Inventors: Andrew T. Koppisch, David T. Fox, Kinya Hotta, John D. Welsh
  • Publication number: 20120138789
    Abstract: Phosphonium-based room temperature ionic liquids (“RTILs”) were prepared. They were used as matrices for Matrix-Assisted Laser Desorption Ionization (MALDI) mass spectrometry and also for preparing samples of dyes for analysis.
    Type: Application
    Filed: December 2, 2010
    Publication date: June 7, 2012
    Applicant: Los Alamos National Security, LLC
    Inventors: Rico E. Del Sesto, Andrew T. Koppisch, Katherine S. Lovejoy, Geraldine M. Purdy
  • Publication number: 20080220441
    Abstract: X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical, for estimating the binding selectivity of a chemical versus chemical analogs, for measuring post-translational modifications of proteins, and for drug manufacturing.
    Type: Application
    Filed: October 10, 2007
    Publication date: September 11, 2008
    Inventors: Eva R. Birnbaum, Andrew T. Koppisch, Sharon M. Baldwin, Benjamin P. Warner, T. Mark McCleskey, Jeffrey Joseph Stewart, Jennifer A. Berger, Michael N. Harris, Anthony K. Burrell